Meribank Biotech Co., Ltd. logo

Meribank Biotech Co., Ltd. (4724)

Market Closed
11 Aug, 05:30
TWSE TWSE
NT$
8. 94
-0.03
-0.3344%
NT$
1.47B Market Cap
- P/E Ratio
- Div Yield
74,558 Volume
- Eps
NT$ 8.97
Previous Close
Add Transaction
Day Range
8.52 9.31
Year Range
8.52 24.75
Want to track 4724 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

4724 closed today lower at NT$8.94, a decrease of -0.3344% from yesterday's close, completing a monthly decrease of -11.4851% or -NT$1.16. Over the past 12 months, 4724 stock lost -45.3211%.
4724 is not paying dividends to its shareholders.
The stock of the company had never split.
The company's stock is traded on one exchange.

4724 Chart

People also search for

Chunghwa Chemical Synthesis & Biotech Co., Ltd.
NT$ 36.1
-1.3661%
Chang Type Industrial Co., Ltd.
NT$ 21.5
-2.0501%
Sheh Fung Screws Co., Ltd.
NT$ 37.5
+6.383%
Taiwan Name Plate Co., Ltd.
NT$ 32.45
0%
Sinher Technology Inc.
NT$ 18.95
-1.8135%

Meribank Biotech Co., Ltd. (4724) FAQ

What is the stock price today?

The current price is NT$8.94.

On which exchange is it traded?

Meribank Biotech Co., Ltd. is listed on TWSE.

What is its stock symbol?

The ticker symbol is 4724.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 1.47B.

Has Meribank Biotech Co., Ltd. ever had a stock split?

No, there has never been a stock split.

Meribank Biotech Co., Ltd. Profile

Biotechnology Industry
Healthcare Sector
- CEO
TWSE Exchange
TW0004724000 ISIN
Taiwan Country
- Employees
- Last Dividend
- Last Split
- IPO Date

Overview

Meribank Biotech Co., Ltd. is a pioneering entity in the biotechnology sector, based in Taipei City, Taiwan, since its founding in 2013. The company specializes in the innovative field of mesenchymal stem cell technology, with a primary focus on the manufacturing, development, and storage of these vital cells. Their work extends into the realm of placental umbilical cord mesenchymal stem cells, cord blood hematopoietic stem cells, and immune cells, maintaining a leading edge in biotechnological advancements and applications.

Products and Services

  • Placental Umbilical Cord Mesenchymal Stem Cells Storage

    This service provides a cutting-edge solution for storing placental umbilical cord mesenchymal stem cells, which are critical for various regenerative medicine applications. These stem cells have the potential to differentiate into multiple cell types, making them invaluable for research and therapeutic uses.

  • Cord Blood Hematopoietic Stem Cells Storage

    Meribank Biotech offers specialized services for the collection, processing, and cryogenic storage of cord blood hematopoietic stem cells. These cells are a key component in treating blood and immune system disorders, presenting a significant breakthrough in medical treatments and patient care.

  • Immune Cells Storage

    Aiding in the advancement of immunotherapy, the company provides facilities for the storage of immune cells. This service is crucial for patients undergoing treatments that require the use of their immune cells at a later stage, offering a beacon of hope for many battling chronic conditions.

  • Cell Cryopreservation Protocol

    Meribank Biotech's expertise also extends to the development and application of cell cryopreservation protocols. By employing state-of-the-art techniques, the company ensures the long-term viability of cells, which is pivotal for their use in future medical treatments and research initiatives.

  • Postpartum Nursing Services

    In addition to its biotechnological services, Meribank Biotech Co., Ltd. delves into the care sector with postpartum nursing services. This initiative aligns with the company's comprehensive approach to supporting family health and well-being, emphasizing the importance of care during the crucial postpartum period.

Contact Information

Address: No.68, Neihu Road
Phone: 886 2 8978 7777